Savvy Updates, 7/24/23: Exocrine Pancreatic Insufficiency, Dahlias & T1D, Volagidemab (GCGR), Pharma Sues Medicare, CODEX the Gut, Tight Control OK for Retinopathy, Early Risers vs. Night Owls, Overcoming Burnout

Savvy Updates, 7/24/23: Exocrine Pancreatic Insufficiency, Dahlias & T1D, Volagidemab (GCGR), Pharma Sues Medicare, CODEX the Gut, Tight Control OK for Retinopathy, Early Risers vs. Night Owls, Overcoming Burnout

New Systematic Review of Exocrine Pancreatic Insufficiency (EPI) In Type 1 Diabetes and Type 2 Diabetes – Focusing on Prevalence and Treatment by Dana Lewis for DIYPS.org, 13 July 2023.         I’m thrilled that the research I did evaluating the...
Savvy Updates, 7/17/23: Tandem Mobi APPROVED, Insulet 510k Filing for iOS App, Friends for Life with Dr. Irl Hirsch and Dr. Viral Shah, TCOYD on Inhaled Insulin & Rapid Acting Insulins, AI in T1D, Closed-Loop Systems Worldwide

Savvy Updates, 7/17/23: Tandem Mobi APPROVED, Insulet 510k Filing for iOS App, Friends for Life with Dr. Irl Hirsch and Dr. Viral Shah, TCOYD on Inhaled Insulin & Rapid Acting Insulins, AI in T1D, Closed-Loop Systems Worldwide

FDA clears Tandem Diabetes Care’s Mobi durable automated insulin pump by Sean Whooley for DrugDeliveryBusiness.com, 11 July 2023. Tandem Diabetes Care announced that the FDA cleared its Tandem Mobi automated insulin delivery (AID) system.  Clearance covers...
Savvy Updates 6/26/22: Plant-based Oral Insulin, On GLP-1s, Pharma Lobby Sues U.S. Govt., Machine-Learning as BG Controllers, Exercise Difficult for T1Ds, TCOYD on Insulins, TCOYD ONE 2023

Savvy Updates 6/26/22: Plant-based Oral Insulin, On GLP-1s, Pharma Lobby Sues U.S. Govt., Machine-Learning as BG Controllers, Exercise Difficult for T1Ds, TCOYD on Insulins, TCOYD ONE 2023

Is plant-based, oral insulin within reach for diabetes treatment? by Paul Ian Cross for MedicalNewsToday.com, 21 June 2023.   New research, published in the journal Biomaterials, suggests that a plant-based oral delivery method of proinsulin could...
Savvy Updates 6/19/23: DIY vs. Commercial Closed-Loop Systems, Dexcom Private Deals w/ PBMs and How Senseonics Finds a Loophole, FDA’s Tap Program, Scoparia Dulcis & Retinopathy, Stress & Comfort Food, Which Sense Evolved First?, Doctors & “Moral Injury”

Savvy Updates 6/19/23: DIY vs. Commercial Closed-Loop Systems, Dexcom Private Deals w/ PBMs and How Senseonics Finds a Loophole, FDA’s Tap Program, Scoparia Dulcis & Retinopathy, Stress & Comfort Food, Which Sense Evolved First?, Doctors & “Moral Injury”

Do-It-Yourself (DIY) vs. Commercial Closed-Loop Systems for Managing Type 1 Diabetes, an upcoming presentation by Dana M. Lewis, developer of OpenAPS, to the American Diabetes Association 83rd Scientific Sessions, 23 June 2023. What is your presentation about? This...
Skip to content